Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05477147 · ClinicalTrials.gov registry record · NA
Re-Ablation Using a Tailored Approach Targeting EGM-Dispersion
A NA study, sponsored by Volta Medical.
- Completed
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT05477147: Completed NA study, sponsored by Volta Medical.
NCT05477147 is a NA study that has completed, run by Volta Medical. The registered enrollment target is 96 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05477147, a NA study, has completed, sponsored by Volta Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
Multi-center, international, non-randomized clinical trial evaluating the use of Volta's VX1 algorithm as used in combination with repeat catheter ablation after AF recurrence after previous catheter ablation.
Primary Outcome
Percent of patient free from recurrent AF episodes of \>30 seconds at 1 year after 1 study redo procedure
Interventions
- DEVICE Catheter Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2023-03-17 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
What the finished NCT05477147 record still lists
NCT05477147 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Catheter Ablation is the first listed.
NCT05477147 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05477147 about?
NCT05477147 is a clinical study titled "Re-Ablation Using a Tailored Approach Targeting EGM-Dispersion". Multi-center, international, non-randomized clinical trial evaluating the use of Volta's VX1 algorithm as used in combination with repeat catheter ablation after AF recurrence after previous catheter ablation.
What is the current status of trial NCT05477147?
This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2023-03-17. Estimated completion is 2025-09-30.
What interventions are being tested in trial NCT05477147?
The interventions under investigation include: Catheter Ablation (DEVICE).
Who is sponsoring clinical trial NCT05477147?
This trial is sponsored by Volta Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05477147's enrollment target sits among peer trials
96 925th of 2000 higher than 1,070 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI